INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that the Acreage Pharms Ltd ("Acreage Pharms") 33,000 square foot, purpose built Phase 2 production facility is complete.  Land clearing and site preparation for its 80,000 square foot Phase 3 expansion project has commenced giving the licensed producer a total of 120,000 square feet of growing space by the end of 2018. Acreage Pharms is also working on plans to increase total capacity to 360,000 square feet in 2019. Invictus is fully funded for the Phase 3 expansion.

Acreage Pharms Phase 1 & Phase 2 (CNW Group/Invictus MD Strategies)

In addition, Acreage Pharms added eight more strains to its cannabis cultivation portfolio, a range of Indica, Sativa, and hybrids that add even more depth and breadth to Acreage Pharms' ambitious cultivation program.

"Acreage Pharms keeps hitting important timeline milestones, something we all champion," said Invictus Chairman and CEO Dan Kriznic. "Cannabis is a highly regulated industry with a wide range of important regulatory requirements that all companies face as they build, cultivate and eventually sell and distribute cannabis. Efficient teamwork, as well as diligent attention to detail, are vital for the achievement of milestones in a timely fashion. The Acreage Pharms team, led by Acreage Pharms CEO Trevor Dixon, is executing at a high level, and we all are thrilled with the progress."

Crafting a well-rounded portfolio of high-quality strains is important for all companies that grow cannabis. Acreage Pharms' cultivation program continues to expand as Canada draws nearer to recreational legalization. The eight new strains build upon Acreage Pharms' already impressive portfolio.

• Mazar, expected 19.5 percent THC. This indica-dominant hybrid strain originally hails from Northern Afghanistan — it is named after the city Mazar-I-Sharif — and is known for an impressive yield of resinous flower. Mazar is high in CBD, a non-psychoactive cannabinoid that has grown in popularity worldwide.
• Outlaw Amnesia, expected 15 percent THC. Outlaw is a sativa-dominant hybrid strain with an earthy, lemony aroma and flavor. It is well known as an excellent indoor growing strain.
• The Ultimate, expected 15-18 percent THC. This hybrid is roughly evenly divided between sativa and indica, and produces forest-green nuggets shaped like pine trees that have a citrus flavor.
• Orange Hill Special, expected 21 percent THC. You could walk through an orange orchard, or you could just inhale a bud of Orange Hill Special — one of the most citrus-forward strains in cannabis. The popular hybrid is evenly divided between indica and sativa.
• Ultra Skunk, expected 11 percent THC.
• CBD Kush, expected 1-1 THC/CBD ratio. The rise of the cannabinoid CBD is an important movement in cannabis, and this evenly balanced sativa-indica hybrid is treasured among CBD fans.
• Sensi Star/Bruce Banner cross. This hybrid of the indica-dominant Sensi Star with sativa-dominant Bruce Banner combines two classic cannabis strains into a single consumer-friendly package.
• White Widow, expected 18.9 percent THC. This famous strain first gained notice in the 1990s, and was routinely referenced on the TV show Weeds. A sativa-dominant hybrid, White Widow gets its name from the white crystals that shroud the buds.